Assessing risks and outcomes in patients with mitral regurgitation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with moderate to severe mitral regurgitation (MR) during hospitalization. It aims to identify prognostic risk factors associated with MR and develop a clinical model to aid in decision-making for treatment. By analyzing data from a prospective cohort, the study seeks to enhance understanding of mortality and heart failure hospitalization risks in MR patients. The findings could potentially inform better management strategies for individuals suffering from this condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with ≥ moderate mitral regurgitation during hospitalization.
* Aged over 18 yrs.

Exclusion Criteria:

* Patients unable to provide written consent.

Where it's running

• The First Affiliated Hospital of Sun Yat-sen Univerity
  Guangzhou, Guangdong, China Recruiting

Study contacts

• Study coordinator: Xiaodong Zhuang, MD
• Email: zhuangxd3@mail.sysu.edu.cn
• Phone: +8613760755035

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Capstan TMVR Feasibility for Mitral Regurgitation

  This early feasibility study tests the Capstan Compass Robotic System to replace the mitral valve in adults with symptomatic, moderate-to-severe or severe mitral regurgitation who aren’t candidates for surgical repair or standard edge-to-edge repair.

  Recruiting Capstan Medical · San Francisco, California and 2 other locations · NCT07917208

• Transcatheter repair for atrial functional mitral regurgitation in high-risk patients

  This trial tests whether adding a catheter-based mitral valve repair (TEER) to optimized medical therapy helps adults with atrial functional MR who are at high surgical risk.

  Recruiting China National Center for Cardiovascular Diseases · Beijing · NCT07741253

• MitraFix transcatheter mitral valve system for high-risk severe mitral regurgitation

  This trial will test the MitraFix transcatheter mitral valve system to see if it can be safely implanted and reduce severe leaky mitral valves in adults at high risk for open-heart surgery.

  Recruiting Mitrassist Lifesciences Limited Co., Ltd. · Beijing, Beijing Municipality · NCT07501234

• Transcatheter Mitral and Tricuspid Interventions and Cardiac MRI Registry

  This study will collect imaging and clinical data from adults undergoing transcatheter mitral or tricuspid procedures to see how their heart structure and function change over time using MRI and advanced ultrasound.

  Recruiting Centro Cardiologico Monzino · Milan, Milan · NCT07370467

• DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease

  This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.

  Recruiting Columbia University · New York, New York · NCT07197736

• Segeberg registry for mitral clip (M-TEER) in severe mitral regurgitation

  This registry follows people with severe mitral regurgitation who get a mitral valve clip (M-TEER) at the Segeberg heart center to see how they do over time.

  Recruiting Segeberger Kliniken GmbH · Bad Segeberg, Schleswig-Holstein · NCT07045753

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.